1. Cryer PE. Hypoglycemia in Diabetes, 3rd Edition. American Diabetes Association, Alexandria, VA, 2016.
  2. Khunti K, Alsifri S, Aronson R, et al. Rates and predictors of hypoglycaemia in 27,585 people from 24 countries with insulin-treated type 1 and type 2 diabetes: the global HAT study. Diabetes Obes Metab 2016;18:907-915.
  3. International Hypoglycaemia Study Group. Glucose concentrations of less than 3.0 mmol/L (54 mg/dL) should be reported in clinical trials: a joint position statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2017;40:155-157.
  4. Riddlesworth T, Price D, Cohen N, Beck RW. Hypoglycemic event frequency and the effect of continuous glucose monitoring in adults with type 1 diabetes using multiple daily insulin injections. Diabetes Ther 2017;8:947-951.
  5. Bliss M. The Discovery of Insulin. University of Chicago Press, Chicago, IL, 1982, p 109 and p 158 respectively.
  6. Bonds DE, Miller ME, Bergenstal RM, et al. The association between symptomatic, severe hypoglycaemia and mortality in type 2 diabetes: retrospective epidemiological analysis of the ACCORD study. BMJ2010;340:b4909.
  7. Zoungas S, Patel A, Chalmers J, et al., ADVANCE Collaborative Group. Severe hypoglycemia and risk of vascular events and death. N Engl J Med 2010;363:1410-1418.
  8. Pieber TR, Marso SP, McGuire B, et al. Temporal relationships between severe hypoglycemia, cardiovascular outcomes and mortality. Diabetologia 2017: in press
  9. Zinman B, Marso SP, Christiansen E, et al. Severe hypoglycemia, cardiovascular outcomes and death. Diabetes2017;66(Suppl 1):A95.
  10. ORIGIN Trial Investigators. Does hypoglycaemia increase the risk of cardiovascular events?  A report from the ORIGIN trial. Eur Heart J 2013;34:3137-3144.
  11. Diabetes Control and Complications Trial (DCCT)/Epidemiology of Diabetes Interventions and Complications (EDIC) Research Group. Association between 7 years of intensive treatment of type 1 diabetes and long-term mortality. JAMA 2015;313:45-53.
  12. Finfer S, Liu B, Chittock DR, et al., NICE-SUGAR Study Investigators. Hypoglycemia and risk of death in critically ill patients. N Engl J Med 2012;367:1108-1118.
  13. Krinsley JS, Maurer P, Holewinski S, et al. Glucose control, diabetes status, and mortality in critically ill patients:  the continuum from intensive care unit admission to hospital discharge.  Mayo Clinic Proc 2017;92:1019-1029.
  14. Tanenberg RJ, Newton CA, Drake AT III. Confirmation of hypoglycemia in the “dead-in-bed” syndrome, as captured by a retrospective continuous glucose monitoring system. Endocr Pract 2010;16:244-248.
  15. Deckert T, Poulsen JE, Larsen M. Prognosis of diabetics with diabetes onset before the age of thirtyone. I. Survival, cause of death and complications. Diabetologia 1978;14:363-370.
  16. Liang SP, Swerdlow AJ, Slater SD, et al. The British Diabetic Association Cohort Study. I. All-cause mortality in patients with insulin-treated diabetes mellitus. Diabet Med 1999;16:459-465.
  17. Patterson CC, Dahlquist G, Harjutsalo V, et al. Early mortality in EURODIAB population-based cohorts of type 1 diabetes diagnosed in childhood since 1989. Diabetologia 2007;50:2439-2442.
  18. Feltbower RG, Bodansky HJ, Patterson CC, et al. Acute complications and drug misuse are important causes of death for children and young adults with type 1 diabetes. Diabetes Care 2008;31:922-926.
  19. Skrivarhaug T, Bangstad HJ, Stene LC, et al.  Long-term mortality in a nationwide cohort of childhood-onset type 1 diabetic patients in Norway. Diabetologia 2006;49:298-305.
  20. Pistrosch F, Ganz X, Bornstein SR, et al. Risks of and risk factors for hypoglycemia and associated arrhythmias in patients with type 2 diabetes and cardiovascular disease: a cohort study under real-world conditions. Acta Diabetol 2015;52:889-895.
  21. Novodvorsky P, Bernjak A, Chow E, et al. Diurnal differences in risk of cardiac arrhythmias during spontaneous hypoglycemia in young people with type 1 diabetes. Diabetes Care 2017;40:655-662.
  22. Chow E, Bernjak A, Walkinghaw E, et al. Cardiac autonomic regulation and repolarization during acute experimental hypoglycemia in type 2 diabetes. Diabetes 2017;66:1322-1333.
  23. Goto A, Arah OA, Goto M, et al. Severe hypoglycaemia and cardiovascular disease: systematic review and meta-analysis with bias analysis. BMJ 2013;347:f4533.
  24. Cryer PE. Glycemic goals in diabetes: trade-off between glycemic control and iatrogenic hypoglycemia. Diabetes2014;63:2188-2195.
  25. The Diabetes Control and Complications Trial Research Group. Hypoglycemia in the Diabetes Control and Complications Trial. Diabetes 1997;46:271-286.
  26. Gubitosi-Klug RA, Braffett BH, White NH, et al., and the Diabetes Control and Complications Trial (DCCT)/Epidemiology of Diabetes Interventions and Complications (EDIC) Research Group. Risk of severe hypoglycemia in type 1 diabetes over 30 years of follow-up in the DCCT/EDIC study. Diabetes Care2017;40:1010-1016.
  27. Action to Control Cardiovascular Risk in Diabetes Study Group. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 2008;358:2545-2559.
  28. ADVANCE Collaborative Group. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 2008;358:2560-2572.
  29. Duckworth W, Abraira C, Moritz T, et al., VADT Investigators. Intensive glucose control and complications in American veterans with type 2 diabetes. N Engl J Med 2009;360:129-139.C
  30. Rodríguez-Gutiérrez R, Montori VM. Glycemic control for patients with type 2 diabetes mellitus:  our evolving faith in the face of evidence. Circ Cardiovasc Qual Outcomes 2016;9:504-512.
  31. Turnbull FM, Abraira C, Anderson RJ, et al.  Intensive glucose control and macrovascular outcomes in type 2 diabetes. Diabetologia 2009;52:2288-2298.
  32. The Diabetes Control and Complications Trial (DCCT)/Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Group. Mortality in type 1 diabetes in the DCCT/EDIC versus the general population.Diabetes Care 2016;39:1378-1383.
  33. Palta P, Huang ES, Kalyani RR, Golden SH, Yeh HC. Hemoglobin A1C and mortality in older adults with and without diabetes:  results from the National Health and Nutrition Examination Surveys (1988-2011). Diabetes Care 2017;40:453-460.
  34. Diabetes Control and Complications Trial (DCCT)/Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Group. Intensive diabetes treatment and cardiovascular outcomes in type 1 diabetes: The DCCT/EDIC Study 30-year follow-up. Diabetes Care 2016;39:686-693.
  35. Nathan DM. Diabetes: advances in diagnosis and treatment. JAMA 2015;314:1052-1062.
  36. Inzucchi SE, Bergenstal RM, Buse JB, et al.  Management of hyperglycemia in type 2 diabetes, 2015: a patient-centered approach: update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2015;38:140-149.
  37. Chiang JL, Kirkman MS, Laffel LM, Peters AL, and the Type 1 Diabetes Sourcebook Authors. Type 1 diabetes through the life span: a position statement of the American Diabetes Association. Diabetes Care 2014;37:2034-2054.